Related Experiment Video
Updated: Oct 23, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
COVID-19 in children: clinical and epidemiological spectrum in the community
César García-Vera1, Sandra Castejón-Ramírez2, Elena Laín Miranda3
1Primary Health Care Center "José Ramón Muñoz Fernández", Zaragoza, Spain. cgarciavera@gmail.com.
Insights
Pediatric COVID-19 in Spain, diagnosed with widespread testing, revealed mild symptoms in over half of cases. Transmission primarily occurred within families, with rare severe outcomes in children under 15.
Area of Science:
- Epidemiology
- Infectious Diseases
- Pediatrics
Background:
- Early pediatric COVID-19 studies in Spain were limited by diagnostic tool availability.
- Previous research focused on initial pandemic phases, potentially underrepresenting the infection's true spectrum.
- Widespread diagnostic access is crucial for accurate pediatric SARS-CoV-2 epidemiology.
Purpose of the Study:
- To determine the real-world spectrum of pediatric COVID-19 in Aragón, Spain.
- To analyze infection epidemiology, clinical presentation, and outcomes in children aged 0-14 years.
- To assess the impact of enhanced diagnostic capabilities on case detection.
Main Methods:
- A descriptive and analytical observational study of pediatric cases (0-14 years) in Aragón from May to October 2020.
- Diagnosis via PCR, rapid antigen tests, or positive IgG serology.
- Inclusion of cases identified through symptoms and contact tracing.
Main Results:
- 5933 positive pediatric cases were identified; 50.3% were asymptomatic.
- Family environment was the primary source of infection (67.8%).
- Fever and cough were most common symptoms; hospitalizations (0.52%), ICU admissions (0.05%), and one death (0.02%) were rare. Infants (<1 year) showed higher symptom and hospitalization rates.
Conclusions:
- SARS-CoV-2 infection in children under 15 resembles other mild respiratory viral infections.
- High asymptomatic rates, predominantly family-based transmission, mild symptoms, and infrequent complications characterize pediatric COVID-19.
- Enhanced diagnostics improved the understanding of pediatric SARS-CoV-2 epidemiology and clinical manifestations.
Abstract:
Most publications on pediatric COVID-19 in Spain were performed at the beginning of the pandemic when some diagnostic tools were not widely available. This study aims to show the real spectrum of the infection based on wide detection of cases due to symptoms and contact tracing. A descriptive and analytical observational study was performed including pediatric cases (0 to 14 years) from the region of Aragón between May 12 and October 31, 2020. Diagnostics was by PCR detection of viral RNA, rapid antigen detection test, or positive IgG serology. There were 5933 positive children included. Of them, 49.03% were women. The mean age was 7.53 ± 4.28 years. The source of infection could not be determined in 17.8% of cases. As for the rest, was determined to be within the family environment in 67.8%. The percentage of asymptomatic patients was 50.3%. Among symptomatic patients, fever (58.1%) and cough (46.7%) were the most frequent symptoms. Hospitalization was required in 0.52% of infected, intensive care unit admission was on 0.05%, and there was one death (0.02%). Children under the age of one presented some symptoms more frequently (71.6% vs 48.5%; OR 2.68; 95% CI 2.08 to 3.45; p < 0.001) and required more hospitalizations (3.9% vs 0.34%; OR 11.52; 95% CI 5.65 to 23.52; p < 0.001).Conclusion: In our environment, SARS-CoV-2 infection is like other mild respiratory viral infections in the population under the age of 15. The contagion occurs mainly in the family environment, the number of asymptomatic is high, being the symptoms mild and the complications very infrequent. What is Known: • Pediatric infection produced by SARS-CoV-2 has manifested as a mild disease in relation to adult age, although with higher affectation at the youngest ages. • Nearly all studies on epidemiology and clinical spectrum of the disease were conducted with patients diagnosed at the beginning of the pandemic. By then, diagnostic tools were only available in hospitals and in emergency units. What is New: • Once diagnostic means were available in primary care medicine and were used not only for the diagnosis of clinical symptoms of the patient, but for the tracing of case contacts, a much more precise approach to the epidemiology and clinical manifestations of the disease was allowed, as described in this study.
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.

